The COPD Pipeline, 2004-2014.
作者信息
Gross Nicholas
机构信息
St Francis Hospital, Hartford, CT.
出版信息
Chronic Obstr Pulm Dis. 2014 May 6;1(1):47-50. doi: 10.15326/jcopdf.1.1.2014.0118.
Abstract
摘要
相似文献
1
The COPD Pipeline, 2004-2014.慢性阻塞性肺疾病研发管线，2004 - 2014年
Chronic Obstr Pulm Dis. 2014 May 6;1(1):47-50. doi: 10.15326/jcopdf.1.1.2014.0118.
2
Retrospective analysis to describe associations between tumor necrosis factor alpha inhibitors and COPD-related hospitalizations.进行回顾性分析以描述肿瘤坏死因子α抑制剂与慢性阻塞性肺疾病（COPD）相关住院之间的关联。
Int J Chron Obstruct Pulmon Dis. 2017 Jul 19;12:2085-2094. doi: 10.2147/COPD.S127815. eCollection 2017.
3
Comparative safety of biologic versus conventional synthetic DMARDs in rheumatoid arthritis with COPD: a real-world population study.比较生物制剂与常规合成改善病情抗风湿药在合并 COPD 的类风湿关节炎中的安全性：一项真实世界人群研究。
Rheumatology (Oxford). 2020 Apr 1;59(4):820-827. doi: 10.1093/rheumatology/kez359.
4
Biologic Therapy in Chronic Obstructive Pulmonary Disease.慢性阻塞性肺疾病的生物治疗
Immunol Allergy Clin North Am. 2017 May;37(2):345-355. doi: 10.1016/j.iac.2017.01.009.
5
Impact of roflumilast on exacerbations of COPD, health care utilization, and costs in a predominantly elderly Medicare Advantage population.罗氟司特对慢性阻塞性肺疾病（COPD）急性加重、医疗保健利用及成本的影响：以老年医保优势人群为主的研究
Int J Chron Obstruct Pulmon Dis. 2015 Mar 16;10:565-76. doi: 10.2147/COPD.S79025. eCollection 2015.
6
Comparison of hospitalizations, emergency department visits, and costs in a historical cohort of Texas Medicaid patients with chronic obstructive pulmonary disease, by initial medication regimen.根据初始药物治疗方案，对德克萨斯州医疗补助慢性阻塞性肺疾病患者历史队列中的住院情况、急诊科就诊情况及费用进行比较。
Clin Ther. 2007 Jun;29(6):1203-13. doi: 10.1016/j.clinthera.2007.06.006.
7
Cost-effectiveness analysis of umeclidinium/vilanterol for the management of patients with moderate to very severe COPD using an economic model.使用经济模型对乌美溴铵/维兰特罗治疗中度至非常严重慢性阻塞性肺疾病（COPD）患者的成本效益分析。
Int J Chron Obstruct Pulmon Dis. 2017 Mar 24;12:997-1008. doi: 10.2147/COPD.S124420. eCollection 2017.
8
Burden of chronic obstructive pulmonary disease in Medicare beneficiaries residing in long-term care facilities.长期护理机构中医疗保险受益人的慢性阻塞性肺疾病负担
Am J Geriatr Pharmacother. 2009 Oct;7(5):262-70. doi: 10.1016/j.amjopharm.2009.11.003.
9
Healthcare costs with tiotropium plus usual care versus usual care alone following 1 year of treatment in patients with chronic obstructive pulmonary disorder (COPD).慢性阻塞性肺疾病（COPD）患者接受噻托溴铵加常规护理与仅接受常规护理治疗1年后的医疗费用。
Pharmacoeconomics. 2004;22(11):741-9. doi: 10.2165/00019053-200422110-00004.
10
Pharmacoeconomic evaluation of COPD.慢性阻塞性肺疾病的药物经济学评价
Chest. 2000 Nov;118(5):1278-85. doi: 10.1378/chest.118.5.1278.
引用本文的文献
1
The Launch of a New COPD Journal.一本新的慢性阻塞性肺疾病杂志的创刊
Chronic Obstr Pulm Dis. 2014 May 6;1(1):1-3. doi: 10.15326/jcopdf.1.1.2014.0128.
本文引用的文献
1
The COPD Pipeline.慢性阻塞性肺疾病（COPD）研发管线
COPD. 2009 Dec;6(6):488-9. doi: 10.3109/15412550903368417.
Zotero 插件